|
Promega Corporation is proud to announce a collaboration agreement with the Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences.The agreement is designed to co-develop compound profiling solutions for small molecule and traditional Chinese medicine drug screening. By combing the drug discovery expertise of GIBH with the biological assay expertise of Promega, the partnership is intended to deliver turnkey services to pharmaceutical companies interested in speeding up their lead discovery and lead optimization processes.
GIBH scientists will offer contract services designed to profile the biology of potential leads using the Promega suite of biological drug screening assays. Initial plans call for development of Cytochrome P450, Cytotoxicity, Kinase and GPCR profiling assays. GIBH will use the assays both in house for own discovery programs as well as offer them on a contract basis to outside companies.
About GIBH
Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences, established from scratch since 2004, is the first integrated research organization that focuses on translational research and drug discovery in China. It has four disease-focused research areas which include: Infectious Diseases, Cancers, Metabolic Diseases and Cardiovascular Diseases. Recently, the institute has launched a new research center for regenerative medicine and stem cell. The mission of GIBH is to improve the health of the general public through promoting innovative research and integrating key technologies to facilitate the development of novel medicines. Most of its senior investigators received their education and training abroad. GIBH welcomes collaborations with various pharmaceutical companies and other related research institutions. For more information about GIBH, please visit the website: www.gibh.ac.cn
About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 1,450 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in twelve countries and 54 global distributors. Annual sales exceed $190 million.
|
